---
figid: PMC9260738__ol-24-02-13404-g00
figtitle: 'Hypoxia-inducible factor-1A: A critical target for inhibiting the metastasis
  of hepatocellular carcinoma'
organisms:
- Homo sapiens
- Mus musculus
- Taraxacum officinale
pmcid: PMC9260738
filename: ol-24-02-13404-g00.jpg
figlink: /pmc/articles/PMC9260738/figure/f1-ol-24-02-13404/
number: F1
caption: Structure and synthetic pathway of HIF-1α. (A) Structure of HIF-1α. (B) (a)
  High expression of HDAC5 in hepatocellular carcinoma leads to silencing of HIPK2,
  which in turn induces the upregulation of HIF-1α. (b) M2-phenotype TAMs release
  IL-1β in the presence of persistent hypoxia and inflammation, which promotes HIF-1α
  synthesis. (c) DAAM can induce HIF-1α by reducing the expression of VHL in hepatoma
  cells. (d) Activated HSCs promote the upregulation of TGM2 in HCC cells through
  inflammatory signals, which can cause VHL depletion and lead to HIF-1α accumulation.
  TAMs, tumor-associated macrophages; IL-1β, interleukin-1β; HDAC5, histone deacetylase5;
  HIF-1α, hypoxia-inducible factor-1α; HIPK2, recombinant homeodomain interacting
  protein kinase 2; HSCs, hepatic stellate cells; VHL, Von Hippel-Lindau; TGM2, transglutaminase
  2; DAAM, Dishevelled-associated activator of morphogenesis.
papertitle: 'Hypoxia-inducible factor-1α: A critical target for inhibiting the metastasis
  of hepatocellular carcinoma.'
reftext: Huan Chen, et al. Oncol Lett. 2022 Aug;24(2):284.
year: '2022'
doi: 10.3892/ol.2022.13404
journal_title: Oncology Letters
journal_nlm_ta: Oncol Lett
publisher_name: D.A. Spandidos
keywords: hepatocellular carcinoma | tumor metastasis | HIF-1α | hypoxia | hypoxia-inducible
  factor-1α
automl_pathway: 0.8561437
figid_alias: PMC9260738__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC9260738__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9260738__ol-24-02-13404-g00.html
  '@type': Dataset
  description: Structure and synthetic pathway of HIF-1α. (A) Structure of HIF-1α.
    (B) (a) High expression of HDAC5 in hepatocellular carcinoma leads to silencing
    of HIPK2, which in turn induces the upregulation of HIF-1α. (b) M2-phenotype TAMs
    release IL-1β in the presence of persistent hypoxia and inflammation, which promotes
    HIF-1α synthesis. (c) DAAM can induce HIF-1α by reducing the expression of VHL
    in hepatoma cells. (d) Activated HSCs promote the upregulation of TGM2 in HCC
    cells through inflammatory signals, which can cause VHL depletion and lead to
    HIF-1α accumulation. TAMs, tumor-associated macrophages; IL-1β, interleukin-1β;
    HDAC5, histone deacetylase5; HIF-1α, hypoxia-inducible factor-1α; HIPK2, recombinant
    homeodomain interacting protein kinase 2; HSCs, hepatic stellate cells; VHL, Von
    Hippel-Lindau; TGM2, transglutaminase 2; DAAM, Dishevelled-associated activator
    of morphogenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TAM
  - STIM1
  - IL18
  - IL10
  - HIPK2
  - TGM2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - VHL
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - HCC
  - HYCC1
  - GJA1
  - Il18
  - Il10
  - Hipk2
  - Tgm2
  - Vhl
  - Hif1a
---
